Trial Profile
Clinical trial of KIB-PCI in healthy Japanese children
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 31 Jan 2018
Price :
$35
*
At a glance
- Drugs Influenza A virus vaccine-H5N1 (Primary)
- Indications Influenza A virus H5N1 subtype
- Focus Pharmacodynamics
- Sponsors Daiichi Sankyo Company; Kitasato Daiichi Sankyo Vaccine
- 07 Jun 2016 New trial record